Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.49
-0.34 (-4.98%)
At close: Mar 18, 2026, 4:00 PM EDT
6.50
+0.01 (0.15%)
Pre-market: Mar 19, 2026, 7:41 AM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $382.42 million as of March 19, 2026. Its market cap has decreased by -12.18% in one year.
Market Cap
382.42M
Enterprise Value
399.68M
1-Year Change
-12.18%
Ranking
Category
Stock Price
$6.49
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $382.42M, a decrease of -82.47%. That is a compound annual growth rate of -29.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 397.56M | -15.83% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 415.16M |
| Anavex Life Sciences | 412.39M |
| PureTech Health | 405.55M |
| Greenwich LifeSciences | 403.86M |
| Benitec Biopharma | 397.82M |
| Enanta Pharmaceuticals | 397.13M |
| Lineage Cell Therapeutics | 392.31M |
| LENZ Therapeutics | 390.34M |